Literature DB >> 27011384

Histamine H3 Receptor Agonist Imetit Attenuated Isoproterenol Induced Renin Angiotensin System and Sympathetic Nervous System Overactivity in Myocardial Infarction of Rats.

C Hass1, B P Panda2, R Khanam3, A K Najmi1, M Akhtar1.   

Abstract

BACKGROUND: Myocardial infarction is an alarming health issue, needs great attention. The present study investigated the role of histamine-H3 receptor (H3R) agonist imetit in relationship to sympathetic and renin angiotensin system in Wistar rats.
MATERIALS AND METHODS: Subcutaneous injection of isoproterenol (85 mg/kg) on last 2 consecutive days in per se group and 7 days treatment of different groups at 24 h interval induced myocardial infarction in Wistar rats. H3R agonist imetit (10 mg/kg), H3R antagonist thioperamide (5 mg/kg), losartan (10 mg/kg) were administered orally to evaluate imetit's cardioprotective potential effect by measuring plasma cardiac antioxidant markers, angiotensin II, norepinephrine levels and histopathological analysis.
RESULTS: Isoproterenol significantly elevated the angiotensin II and norepinephrine levels in rat plasma. This study revealed that pre-treatment with imetit similar to losartan attenuated norepinephrine and angiotensin II levels whereas thioperamide showed its antagonistic effect by diminishing imetit's effects. Furthermore, its protective effect was confirmed by restoration of cardiac antioxidant markers and histopathological improvement of myocardium integrity.
CONCLUSION: This study confirm imetit's cardioprotective potential and also reveals renin angiotensin system, sympathetic system and H3R correlation in isoproterenol induced toxicity in rats. However, molecular studies must be warranted to prove the role of H3R in myocardial infarction. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27011384     DOI: 10.1055/s-0035-1569448

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  4 in total

1.  Histamine provides an original vista on cardiorenal syndrome.

Authors:  Pierre-Louis Tharaux
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

2.  Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming.

Authors:  Kazuyuki Noguchi; Junji Ishida; Jun-Dal Kim; Naoto Muromachi; Koichiro Kako; Hayase Mizukami; Weizhe Lu; Tomohiro Ishimaru; Shohei Kawasaki; Shuzo Kaneko; Joichi Usui; Hiroshi Ohtsu; Kunihiro Yamagata; Akiyoshi Fukamizu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-28       Impact factor: 11.205

Review 3.  Estrogen Receptors: Therapeutic Perspectives for the Treatment of Cardiac Dysfunction after Myocardial Infarction.

Authors:  Jaqueline S da Silva; Tadeu L Montagnoli; Bruna S Rocha; Matheus L C A Tacco; Sophia C P Marinho; Gisele Zapata-Sudo
Journal:  Int J Mol Sci       Date:  2021-01-07       Impact factor: 5.923

4.  Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties.

Authors:  Kamil J Kuder; Magdalena Kotańska; Katarzyna Szczepańska; Kamil Mika; David Reiner-Link; Holger Stark; Katarzyna Kieć-Kononowicz
Journal:  Molecules       Date:  2021-04-15       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.